A B S T R A C T The mechanisms underlying ethylmalonic-adipic aciduria were studied in a 5-yr-old girl. Oxidation of radioactive substrates by cultured skin fibroblasts from the proband and asymptomatic family members was also determined and compared to that by normal fibroblasts and that by cells from a patient with glutaric aciduria type II.
INTRODUCTION
We have recently described the case of ethylmalonicadipic aciduria who constantly excretes 2-ethylmalonic acid, adipic acid, and N-hexanoylglycine in large amounts in urine (1) . The major clinical symptoms of this patient are intermittent episodes of vomiting, lethargy, acidosis, and hypoglycemia. Hyperglycinuria is also occasionally observed. In the preliminary investigation, only a small amount of glutaric acid was occasionally detected. Inasmuch as the three major urinary metabolites are alternative metabolites of butyryl-CoA (1-3) and hexanoyl-CoA (1, 4), a genetic deficiency of butyryl-CoA dehydrogenase was postulated as a cause ofthis disease. These same metabolites have previously been detected in urine from patients with Jamaican vomiting sickness (2, 4, 5) and a patient with glutaric aciduria type II (6) . In contrast to the findings in the patient with ethylmalonic-adipic aciduria, however, large amounts of glutarate, isobutyrate, and isovalerate were detected in addition to ethylmalonate and adipate in urine of patients with these two previously known diseases. In particular, the amount of glutarate was very large in the patient with glutaric aciduria type II, exceeding by more than 10 times that of any other metabolite including ethylmalonate and adipate (6) . Inhibition of several short-chain acyl-CoA dehydrogenases including glutarylCoA, butyryl-CoA, and isovaleryl-CoA dehydrogenases by an environmental toxin, hypoglycin (5), or by genetic mutation (6) has been proposed as the mechanism(s) of Jamaican vomiting sickness and glutaric aciduria type II, respectively. Only a single case of a neonate with the latter disease has been fully reported' (6) .
We have subsequently carried out an extensive clinical investigation of our patient with ethylmalonicadipic aciduria including loading tests with medium chain triglycerides (MCT),2 lysine, and leucine to determine the metabolic pathways involved. In vitro experiments were also performed using cultured skin fibroblasts to further characterize the disease. Skin fibroblasts from the patient with glutaric aciduria type II were studied biochemically through comparing them to the present case. The results from these in vivo and in vitro investigations are described in this report.
METHODS
Patient. The proband is a white female born by breech delivery after a normal pregnancy to a 44-yr-old gravida 4 , para 3 mother. 7 yr before the patient was born, a female sibling had died on the 3rd d of life after a period of unexplained lethargy. Hepatomegaly with fatty infiltration ofthe liver was found at autopsy. Both parents and the two living male siblings are healthy, and there is no consanguinity in the family.
Symptoms were first noted at 7 wk of age when, after a period of poor oral intake, she presented with a brief episode of tonic seizures (3-4 s) . She recovered spontaneously and on evaluation a few hours later, was normal. A routine laboratory investigation was normal except for a mild elevation of serum lactic dehydrogenase (263 U, normal <255 U) and glutamic-oxaloacetic transaminase (300 U, normal <50 U).
During the following 4 yr, the patient had two episodes of coma and convulsions associated with hypoglycemia and ketoacidosis. The first episode occurred at 1 yr of age while she had mild gastroenteritis. She became increasingly lethargic and developed tonic seizures. She was admitted to a local hospital where moderate hypoglycemia (30 Analytical procedures. Urinary organic acids were analyzed as methyl esters by gas chromatography and the identification of the peaks was done by gas chromatography-mass spectrometry as previously described (7) . Serum short-chain fatty acids were analyzed by gas chromatography using the method of Tanaka et al. (8) . Urines were analyzed for short chain fatty acids after hydrolysis with barium hydroxide (7) .
Urine screening for amino acids was done by one-way high voltage electrophoresis (9) . A Beckman 119CL amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.) was used to quantitate plasma amino acids after specimens were deproteinized with an equal volume of 10% sulfosalicylic acid. Serum carnitine was measured by the method of Marquis and Fritz (10) .
Culture of skin fibroblasts. Skin biopsies were obtained from the proband, her parents, her two nornal male siblings, and six normal subjects. All (11) and these conditions were used in our experiments. The experimental conditions used in this study are summarized in Table I . The addition of glucose as a possible primer was found to be unnecessary. Oxidation of each radioactive substrate by each cell line was tested several times (5-10 for the proband and 2-4 for the others) at different passages. All of the assays were done in triplicate.
Statistic analysis. The significance of the differences between the two groups ofdata was analyzed by the Student's t test.
RESULTS
Urinary organic acids. Organic acid analysis offour random urine specimens collected at 4.5 yr of age, when the child was clinically well, showed a constant excretion of 2-ethylmalonic acid, adipic acid, and hexanoylglycine ( Fig. 1 ) in amounts ranging from 630 to 780 (normal: 3+2 SE), 210-740 (normal: 2-9), and 190-390 (normal: not detectable) ,ug/ml creatinine, respectively, as described in the preliminary report (1) . In two of these specimens, glutaric acid was detected in amounts of80 and 240 ,ug/mg creatinine, but it was undetectable in two others. 2-Methylsuccinic acid was present in all four specimens in amounts 10-15% that ofethylmalonate, and small amounts ofoctanedioic Three random urine specimens were analyzed for short-chain fatty acids after hydrolysis with barium hydroxide. Hexanoic acid excretion was greatly increased (126-222 ,ug/mg creatinine), whereas those of other short chain fatty acids were only moderately elevated (Table III) .
Loading tests. Lysine monohydrochloride, one of the precursors of glutaryl-CoA, was given orally in a dose of 60 mg/kg three times a day for 2 consecutive d as had been described in the case of glutaric aciduria caused by deficiency of glutaconyl-CoA decarboxlase3 (12) . With this loading, the urinary excretion of glutarate in our patient increased from 11 Leucine, the precursor of isovaleryl-CoA, was administered orally in a single dose of 100 mg/kg as had been described for two patients with isovaleric acidemia (8) . Urinary isovalerylglycine (15) , which was undetectable before leucine administration, increased to 373 ,ug/mg creatinine during the first 12 h after leucine ingestion and fell to 82 ,ug/mg creatinine during the second 12 h. Isovalerylglycine was not detectable on the 2 d. Serum isovaleric acid was 120 ,ug/100 ml before the leucine loading, and it rose to 1,200 ,ugll00 ml at 2 h and fell to 440 ,ug/100 ml at 4 h.
MCT were given by mouth in one dose of 1.4 g/kg as the precursor of butyryl-CoA. This dose was onethird the daily amount of MCT used in a ketogenic 3Activities of glutaryl-CoA dehydrogenation to glutaconylCoA and decarboxylation of the latter to crotonyl-CoA cannot be separated by biochemical means available at present (13) . Glutaric aciduria is obviously a result of a genetic de- ficiency of glutaconyl-CoA decarboxylase activity judging from the metabolites that accumulate in patients with this disease (14) , but it has been attributed to a deficiency of glutarylCoA dehydrogenase in some reports for this reason. Separate assays of these two enzyme activities in cells from patients with glutaric aciduria has not been achieved as yet. Blood glucose, electrolytes, and blood ammonia at this point were normal. These episodes of intermittent lethargy were repeated two to three times and the child gradually recovered over a 2-h period. There was a marked increase of ethylmalonate excretion during the first 6 h (Table IV) (Table V) . Subsequent course and effects of low fat diet. 1 wk after the patient had been discharged from the Clinical After discharge, she was given a diet relatively low in fat and high in carbohydrates. The approximate caloric composition of the diet was 20% from fats, 65% from carbohydrates, and 15% from proteins. Urinary organic acids were analyzed on 12 consecutive 24-h urines during this period. In general, the amounts of total urinary organic acids were greatly reduced. In most of the urines, the amount of ethylmalonic acid was by far the largest except on 2 d when the amount of adipate exceeded that of ethylmalonate. Glutarate was detected in small amounts in only two urines (Table VI) .
During a 16-mo period, while she was on the low fathigh carbohydrate diet, she developed four mild episodes of vomiting and lethargy. One of these episodes occurred while she had an upper respiratory infection. The triggering factor in the other three episodes is not clear. In none of these episodes did she become hypoglycemic or acidotic.
Serum carnitine levels. Serum carnitine levels were assayed on two occasions. The two values were 50 and 51 nmol/ml and were within normal range.
Oxidation (Table VII) .
The '4CO2 production from [2-14C] leucine by the proband cells was 23% of the mean of controls. In glutaric aciduria type II, leucine oxidation was more severely impaired, and it was only 9% of the mean of controls (Table VII) .
The 14CO2 production from succinate by fibroblasts from the proband and the patient with glutaric aciduria type II was within the normal range (Table VII) . Therefore, the impairment of oxidation of butyrate, lysine, and leucine in cells from our patient and those from the patient with glutaric aciduria type II is not caused by a decreased viability of the cells. [1-14C] Butyrate oxidation activity of the mother's cells was the highest among those of family members, but it was about 40% of the mean of control values and significantly lower than the lowest control value (Table  VIII) . The same activity of the cells from the father and the older sibling was somewhat lower than that of the mother's cells, but it was significantly higher than that of the proband (P < 0.01). The activity of cells from the other sibling was lower than that of other family members (excluding the proband) and it was only 1.6 (17) , and the oxidation of 2-ethylhydracrylic acid (2-ethyl, 3-hydroxypropionic acid) in the R-pathway of isoleucine (18) . More recently, however, we have shown in rats in vivo using precursors labeled with 13C and 2H at various positions that butyrate can, in fact, be incorporated into urinary ethylmalonate, and that 2-ethylhydroacrylic acid is, for the most part (98%), first converted to butyryl-CoA and then carboxylated (3) . Therefore, the carboxylation of butyryl-CoA is actually the only major mechanism for ethylmalonate synthesis. Adipic acid and hexanoylglycine, on the other hand, are both known to be formed from hexanoic acid, the former by c-oxidation (19) and the latter by conjugation with glycine (4) (Fig. 2) . Thus, the three major abnormal metabolites in this patient appear to have been derived from butyric and hexanoic acids, indicating that the patient had a block in /8-oxidation of fatty acids at the stages of butyryl-CoA and hexanoyl-CoA. These observations led us previously to propose a deficiency of butyryl-CoA dehydrogenase activity as a mechanism of this disease (1) . This hypothesis is further supported in the present study by reduced ability of cultured cells from the proband to oxidize [1-14C] butyrate and also by evidence from the MCT loading test that resulted in a massive urinary excretion of ethylmalonate and marked elevation of butyric and hexanoic acids in blood. These biochemical changes were accompanied by severe transient vomit- ing and lethargy. Crotonic acid and 3-hydroxybutyrate, which are the metabolites immediately following butyryl CoA dehydrogenation, were not detected at all in the patient's blood or urine before and after the loading.
It was important to determine whether pathways other than that of fatty acid oxidation were blocked in the present case as in the case of glutaric aciduria type II, although the spectrum of urinary metabolites was more consistent with a specific deficiency of butyrylCoA dehydrogenase activity. The results from in vitro experiments using cultured skin fibroblasts are rather unexpected in this regard. The abilities of the proband's cells to oxidize both [2-14C] 3, 9 , and 9% ofthe mean ofcontrols, respectively. These activities were much lower than those seen in our proband's cells but the pattern of deficiencies was similar. Thus, the results from in vitro studies as well as those from metabolite analyses indicate that several catabolic pathways including those for fatty acids, lysine, and leucine are blocked at the stage of short-chain acylCoA dehydrogenases in these diseases (Fig. 3) . It has been shown that several specific acyl-CoA dehydrogenases exist for each individual short-chain acylCoA (8, 13 their structure or, alternatively, a protein which is commonly required for the activity ofthese enzymes. Since there is no evidence for common subunit structure in these acyl-CoA dehydrogenases (20) , the latter possibility is more likely. This conclusion is supported by our recent experimental results that activities of mitochondrial butyryl-CoA dehydrogenase and isovaleryl-CoA dehydrogenase were both normal in ethylmalonic acidemia cells and glutaric aciduria type II cells (21) . It is known that these acyl-CoA dehydrogenases require electron transfer flavoprotein (ETF) as the acceptor ofhydrogens subtracted from the substrate (Fig. 4) . There is evidence for a single ETF serving more than one dehydrogenase (22 Although the mutation of the same gene is indicated for the etiology of ethylmalonic aciduria and glutaric aciduria type II, a genetic heterogeneity of these two diseases was evident inasmuch as the degrees of deficient activities for butyrate oxidation of these two cell lines were significantly different (P < 0.001). The hypothesis of more than one mutant allele may also explain the results of the family study. The ability of cells from the father and mother to oxidize [1-14C]-butyrate were lower than the lowest normal value and were 28 and 41% of the mean of controls, respectively, but their values are significantly higher than that of the proband (P < 0.001). This suggests that they are both heterozygotes. The same activity of the cells from two asymptomatic siblings is also low; 34 and 22% of the mean ofcontrols, respectively. The value for the second sibling was significantly higher than that for the proband but considerably lower than that for any other asymptomatic family member. These data on the proband and the asymptomatic family members do not fit single mutant allele, but these may well be explained by assuming that the father and mother each have different mutant alleles of differing severity and that the proband is a genetic compound for these alleles rather than a homozygote for a single mutant allele. This hypothesis, however, must be further tested with more sensitive, specific assay methods. Marked differences also exist between ethylmalonic aciduria and glutaric aciduria type II in clinical severity and metabolite pattern. In glutaric aciduria type II, the amount of glutarate was overwhelmingly large. The increase of ethylmalonic acid was about Y¼s that of glutarate, and was similar to that of urinary ethylmalonate in our patient. The patient with glutaric aciduria type II became severely acidotic immediately after birth and died at the age of 70 h. In the present case, the amount ofglutarate was relatively large only on one occasion when she had a severe acidotic episode. In contrast, the amount of ethylmalonate remained high while the patient was on a low-fat diet but glutarate was usually undetectable during this period.
We performed loading tests on our patient with lysine and leucine in addition to that with MCT to characterize her disease clinically. Pronounced increases in serum isovaleric acid and urinary isovalerylglycine were observed after leucine loading in our patient, but the increase in serum isovaleric acid was 15-50% of that seen in patients with isovaleric acidemia (8) . In spite of the reduced capacity to oxidize [2-14C]lysine in vitro, lysine loading resulted in only a transient increase in glutarate that was much smaller (2%) than that observed in a patient with glutaric aciduria after loading the same amount of lysine (12) . The molecular basis for predominance of ethylmalonate and minor increase of glutarate even after lysine loading in our patient is yet to be elucidated.
In addition to the major metabolites, several other organic acids, were excreted in increased amounts by this patient. These include 2-methylsuccinic acid, and dicarboxylic acids with 8 and 10 carbons. Among them the most constant finding was the excretion of methylsuccinic acid in amounts about 10% of ethylmalonic acid. Since this ratio is very constant, this acid is probably produced by isomerization of ethylmalonylCoA as has been shown in a bacterial system (24) (Fig.   2 ). The formation of dicarboxylic acids with 8 and 10 carbons can be explained by co-oxidation of the corresponding monocarboxylic acids (19) .
An occasional medium-chain dicarboxylic aciduria consisting of adipate, suberate, and sebacate has been observed in a patient with a systemic carnitine deficiency (25) . This disease is characterized by lipid storage myopathy and recurrent episodes of hypoglycemia (26) . Unlike the present patient, however, neither ethylmalonate nor hexanoylglycine was detected (25) , indicating that butyrate and hexanoate oxidation is not inhibited in the patient with camitine deficiency. This finding is consistent with the knowledge that carnitine is not required for mitochondrial butyrate and hexanoate oxidation (27) . Adipate and dicarboxylic acids with 8 and 10 carbons may alternatively be produced by ,-oxidation of dicarboxylic acids with longer chains, which are produced from longchain fatty acids as a result of carnitine deficiency. Normal serum carnitine concentration and lack of myopathy in our patient also indicates that the metabolic derangement in our patient is not caused by carnitine deficiency. Addition of (-)carnitine to incubation media did not restore [1-14C] butyrate oxidation by our proband's cells.
The biochemical mechanism for episodic hypoglycemia seen in this patient may be readily explained by the present knowledge of metabolic regulation. It has been shown that 2-alkyl-substituted malonic acids, such as methylmalonic acid and butylmalonic acid, strongly inhibit mitochondrial malate transport, which is a rate-limiting step in the early phase of gluconeogenesis (28, 29) . Therefore, during periods of poor oral intake and catabolic stress because of infections, an inhibition ofthe malate transport by a high intracellular concentration of ethylmalonate would result in suppression of gluconeogenesis and consequent hypoglycemia. The inhibition of overall fatty acid oxidation is also a contributing factor to the inhibition of gluconeogenesis as has been shown previously (29, 30) .
